Cell Factory Franco Calori, Center for Transfusion Medicine, Cellular Therapy and Cryobiology, Department of Regenerative Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
J Cell Mol Med. 2013 Jan;17(1):168-80. doi: 10.1111/j.1582-4934.2012.01660.x. Epub 2013 Jan 11.
In the last years, mesenchymal stem cells (MSCs) have been identified as an attractive cell population in regenerative medicine. In view of future therapeutic applications, the study of specific differentiation-related gene expression is a pivotal prerequisite to define the most appropriate MSC source for clinical translation. In this context, it is crucial to use stable housekeeping genes (HGs) for normalization of qRT-PCR to obtain validated and comparable results. By our knowledge, an exhaustive validation study of HGs comparing MSCs from different sources under various differentiation conditions is still missing. In this pivotal study, we compared the expression levels of 12 genes (ACTB, Β2M, EF1alpha, GAPDH, GUSB, PPIA, RPL13A, RPLP0, TBP, UBC, YWHAZ and 18S rRNA) to assess their suitability as HGs in MSCs during adipogenic, osteogenic and chondrogenic differentiation. We demonstrated that many of the most popular HGs including 18S rRNA, B2M and ACTB were inadequate for normalization, whereas TBP/YWHAZ/GUSB were frequently identified among the best performers. Moreover, we showed the dramatic effects of suboptimal HGs choice on the quantification of cell differentiation markers, thus interfering with a reliable comparison of the lineage potential properties among various MSCs. Thus, in the emerging field of regenerative medicine, the identification of the most appropriate MSC source and cell line is so crucial for the treatment of patients that being inaccurate in the first step of the stem cell characterization can bring important consequences for the patients and for the promising potential of stem cell therapy.
在过去的几年中,间充质干细胞(MSCs)已被确定为再生医学中具有吸引力的细胞群体。鉴于未来的治疗应用,研究特定分化相关基因的表达是定义最适合临床转化的 MSC 来源的关键前提。在这种情况下,使用稳定的管家基因(HGs)进行 qRT-PCR 的归一化对于获得验证和可比的结果至关重要。据我们所知,仍然缺乏对不同来源的 MSC 在各种分化条件下比较 HG 的详尽验证研究。在这项关键研究中,我们比较了 12 个基因(ACTB、Β2M、EF1alpha、GAPDH、GUSB、PPIA、RPL13A、RPLP0、TBP、UBC、YWHAZ 和 18S rRNA)的表达水平,以评估它们在成脂、成骨和成软骨分化过程中作为 MSC 中的 HG 的适用性。我们证明,包括 18S rRNA、B2M 和 ACTB 在内的许多最受欢迎的 HG 不适合归一化,而 TBP/YWHAZ/GUSB 则经常被认为是表现最好的 HG 之一。此外,我们还展示了选择不合适的 HG 对细胞分化标志物定量的巨大影响,从而干扰了不同 MSC 之间谱系潜能特性的可靠比较。因此,在再生医学这个新兴领域,确定最合适的 MSC 来源和细胞系对于患者的治疗至关重要,因为在干细胞特征描述的第一步不准确可能会对患者和干细胞治疗的有前途的潜力产生重要影响。